FRESENIUS SE & CO KGAA (1FRE.MI) Stock Price & Overview
BIT:1FRE • DE0005785604
Current stock price
The current stock price of 1FRE.MI is 47.28 EUR. Today 1FRE.MI is down by -5.48%. In the past month the price increased by 56.19%.
1FRE.MI Key Statistics
- Market Cap
- 26.63B
- P/E
- 14.78
- Fwd P/E
- 12.72
- EPS (TTM)
- 3.20
- Dividend Yield
- 2.36%
1FRE.MI Stock Performance
1FRE.MI Stock Chart
1FRE.MI Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to 1FRE.MI.
1FRE.MI Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to 1FRE.MI. 1FRE.MI has an average financial health and profitability rating.
1FRE.MI Earnings
On February 25, 2026 1FRE.MI reported an EPS of 0.63 and a revenue of 5.96B. The company missed EPS expectations (-28.85% surprise) and missed revenue expectations (-1.28% surprise).
1FRE.MI Forecast & Estimates
23 analysts have analysed 1FRE.MI and the average price target is 57.07 EUR. This implies a price increase of 20.71% is expected in the next year compared to the current price of 47.28.
For the next year, analysts expect an EPS growth of 16.18% and a revenue growth 4.95% for 1FRE.MI
1FRE.MI Groups
Sector & Classification
1FRE.MI Financial Highlights
Over the last trailing twelve months 1FRE.MI reported a non-GAAP Earnings per Share(EPS) of 3.2. The EPS increased by 6.31% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 5.11% | ||
| ROA | 2.69% | ||
| ROE | 6.14% | ||
| Debt/Equity | 0.61 |
1FRE.MI Ownership
1FRE.MI Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| FRE | FRESENIUS SE & CO KGAA | 12.07 | 25.177B | ||
| FME | FRESENIUS MEDICAL CARE AG | 9.8 | 11.836B | ||
| EUK | EUKEDOS SPA | N/A | 11.484M | ||
| V3V | FAMICORD AG | N/A |
Related stock screener links
View all stocks in the Health Care Services Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Milan Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
About 1FRE.MI
Company Profile
Fresenius SE & Co. KGaA is a healthcare group, which engages in the provision of products and services for dialysis, hospitals, and outpatient medical care. The company is headquartered in Bad Homburg, Hessen. The firm has operationally managed divisions Fresenius Kabi and Fresenius Helios as well as the holdings Fresenius Vamed and Fresenius Medical Care. Fresenius Kabi offers healthcare products for critically and chronically ill patients and offers essential medicines and medical technology for infusion, transfusion and clinical nutrition and its product portfolio includes intravenously administered generic medicines, infusion therapies and clinical nutrition. Fresenius Helios is a private hospital operator that operates clinics, medical facilities, rehabilitation centers and others. Fresenius Vamed provides services for hospitals and other healthcare facilities such as prevention, construction, service and operational management. Fresenius Medical Care offers products and services along the dialysis value chain and is a supplier of dialysis products such as dialysis machines, dialyzers and associated disposable accessories.
Company Info
IPO: 1986-12-18
FRESENIUS SE & CO KGAA
Else-Kroener-Str. 1
BAD HOMBURG HESSEN DE
Employees: 176486
Phone: 4961726080
FRESENIUS SE & CO KGAA / 1FRE.MI FAQ
What does FRESENIUS SE & CO KGAA do?
Fresenius SE & Co. KGaA is a healthcare group, which engages in the provision of products and services for dialysis, hospitals, and outpatient medical care. The company is headquartered in Bad Homburg, Hessen. The firm has operationally managed divisions Fresenius Kabi and Fresenius Helios as well as the holdings Fresenius Vamed and Fresenius Medical Care. Fresenius Kabi offers healthcare products for critically and chronically ill patients and offers essential medicines and medical technology for infusion, transfusion and clinical nutrition and its product portfolio includes intravenously administered generic medicines, infusion therapies and clinical nutrition. Fresenius Helios is a private hospital operator that operates clinics, medical facilities, rehabilitation centers and others. Fresenius Vamed provides services for hospitals and other healthcare facilities such as prevention, construction, service and operational management. Fresenius Medical Care offers products and services along the dialysis value chain and is a supplier of dialysis products such as dialysis machines, dialyzers and associated disposable accessories.
Can you provide the latest stock price for FRESENIUS SE & CO KGAA?
The current stock price of 1FRE.MI is 47.28 EUR. The price decreased by -5.48% in the last trading session.
Does 1FRE stock pay dividends?
FRESENIUS SE & CO KGAA (1FRE.MI) has a dividend yield of 2.36%. The yearly dividend amount is currently 0.
What is the ChartMill rating of FRESENIUS SE & CO KGAA stock?
1FRE.MI has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
What do analysts say about FRESENIUS SE & CO KGAA (1FRE.MI) stock?
23 analysts have analysed 1FRE.MI and the average price target is 57.07 EUR. This implies a price increase of 20.71% is expected in the next year compared to the current price of 47.28.
What is the GICS sector and industry of 1FRE stock?
FRESENIUS SE & CO KGAA (1FRE.MI) operates in the Health Care sector and the Health Care Providers & Services industry.
What is the Price/Earnings (PE) ratio of FRESENIUS SE & CO KGAA (1FRE.MI)?
The PE ratio for FRESENIUS SE & CO KGAA (1FRE.MI) is 14.78. This is based on the reported non-GAAP earnings per share of 3.2 and the current share price of 47.28 EUR.